Vimarsana
Biggest News Aggregation in the World

Page 6 - 12665010 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from 12665010. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In 12665010 Today - Breaking & Trending Today

CVS Health (NYSE:CVS) Lowered to "Market Perform" at Leerink Partnrs - Vimarsana News

CVS Health (NYSE:CVS) Lowered to "Market Perform" at Leerink Partnrs

CVS Health (NYSE:CVS – Get Free Report) was downgraded by Leerink Partnrs from an “outperform” rating to a “market perform” rating in a research note issued to investors on Wednesday, Zacks.com reports. Leerink Partnrs also issued estimates for CVS Health’s Q4 2024 earnings at $1.94 EPS and FY2027 earnings at $9.68 EPS. Several other research […]

Research Analysts Issue Forecasts for CVS Health Co.'s Q4 2024 Earnings (NYSE:CVS) - Vimarsana News

Research Analysts Issue Forecasts for CVS Health Co.'s Q4 2024 Earnings (NYSE:CVS)

CVS Health Co. (NYSE:CVS – Free Report) – Research analysts at Leerink Partnrs lowered their Q4 2024 earnings per share estimates for CVS Health in a note issued to investors on Wednesday, May 1st. Leerink Partnrs analyst M. Cherny now forecasts that the pharmacy operator will post earnings of $1.94 per share for the quarter, […]

CVS Health Co. (NYSE:CVS) Shares Sold by Oder Investment Management LLC - Vimarsana News

CVS Health Co. (NYSE:CVS) Shares Sold by Oder Investment Management LLC

Oder Investment Management LLC lowered its holdings in CVS Health Co. (NYSE:CVS – Free Report) by 20.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,525 shares of the pharmacy operator’s stock after selling 1,696 shares during the quarter. Oder Investment Management LLC’s holdings […]

Source: wkrb13.com
Barclays Trims CVS Health (NYSE:CVS) Target Price to $63.00 - Vimarsana News

Barclays Trims CVS Health (NYSE:CVS) Target Price to $63.00

CVS Health (NYSE:CVS – Get Free Report) had its price target decreased by research analysts at Barclays from $78.00 to $63.00 in a report released on Thursday, Benzinga reports. The firm currently has an “equal weight” rating on the pharmacy operator’s stock. Barclays‘s price objective points to a potential upside of 16.67% from the stock’s […]

Pekin Hardy Strauss Inc. Sells 6,335 Shares of CVS Health Co. (NYSE:CVS) - Vimarsana News

Pekin Hardy Strauss Inc. Sells 6,335 Shares of CVS Health Co. (NYSE:CVS)

Pekin Hardy Strauss Inc. lessened its position in CVS Health Co. (NYSE:CVS – Free Report) by 32.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 13,165 shares of the pharmacy operator’s stock after selling 6,335 shares during the quarter. Pekin Hardy Strauss Inc.’s […]